Trial reportAddictive behaviors2013
Duration effects in contingency management treatment of methamphetamine disorders.
Trial report in Addictive behaviors, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 37 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Behavior Change: Reinforcement Schedule Effects
Expanding Capacity in Alberta to Deliver Contingency Patient Management in Outpatient Addiction Treatment: A Randomized Clinical Trial for Methamphetamine Use
Who cites it
37 citing papers in PubMed, 4 syntheses or guidelines pooled it.
- Psychosocial interventions for stimulant use disorder.The Cochrane database of systematic reviews · 2024Pooled it
- Long-term efficacy of contingency management treatment based on objective indicators of abstinence from illicit substance use up to 1 year following treatment: A meta-analysis.Journal of consulting and clinical psychology · 2021Pooled it
- Comparative efficacy and acceptability of psychosocial interventions for individuals with cocaine and amphetamine addiction: A systematic review and network meta-analysis.PLoS medicine · 2018Pooled it
- A review of the literature on contingency management in the treatment of substance use disorders, 2009-2014.Preventive medicine · 2016Pooled it
- Use of continuous transdermal alcohol monitoring during a contingency management procedure to reduce excessive alcohol use.Drug and alcohol dependence · 2014Trial
- Cost-effectiveness of contingency management for methamphetamine use disorder: A model-based analysis.Addiction (Abingdon, England) · 2026Article
- A double-blind randomized clinical trial of zonisamide and contingency management for alcohol use disorder treatment (ZARRA) protocol.Contemporary clinical trials · 2026Article
- Implementing incentives in family medicine for opioid use disorder treatment: a qualitative inquiry on provider and patient preferences for a low magnitude reward program compatible with buprenorphine treatment.Addiction science & clinical practice · 2025Article
- Implementing contingency management in family medicine: A qualitative inquiry on provider and patient preferences for a low magnitude reward program compatible with buprenorphine treatment.Research square · 2025Article
- Contingency Management for Drug Use Disorders: Meta-Analysis and Application of Tolin's Criteria.Clinical psychology : a publication of the Division of Clinical Psychology of the American Psychological Association · 2024Article
- Psychosocial and pharmacologic interventions for problematic methamphetamine use: Findings from a scoping review of the literature.PloS one · 2023Article
- Demonstration of an app-delivered digital therapeutic program for methamphetamine use disorder.Frontiers in psychiatry · 2023Article
- Discounting of employment opportunities with urine drug testing requirements in opioid users enrolled in the Therapeutic Workplace.Journal of vocational rehabilitation · 2023Article
- A Systematic Review of Treatment Maintenance Strategies in Token Economies: Implications for Contingency Management.Perspectives on behavior science · 2022Review
- What are the ethical implications of using prize-based contingency management in substance use? A scoping review.Harm reduction journal · 2021Article
- A review of research-supported group treatments for drug use disorders.Substance abuse treatment, prevention, and policy · 2021Review
- Long-term functioning to provide empirical support for the clinical relevance of treatment outcomes for methamphetamine use disorders.Journal of substance abuse treatment · 2021Article
- Treatment Response Prediction and Individualized Identification of Short-Term Abstinence Methamphetamine Dependence Using Brain Graph Metrics.Frontiers in psychiatry · 2021Article
- Cues Associated with Alternative Reinforcement During Extinction Can Attenuate Resurgence of an Extinguished Instrumental Response.Learning & behavior · 2019Article
- Interventions to Reduce Drug Use Among Methamphetamine Users at Risk for HIV.Current HIV/AIDS reports · 2019Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The primary aim of this study was to determine whether different durations of contingency management (CM) in conjunction with psychosocial treatment produced different rates of abstinence among methamphetamine dependent individuals. Participants were randomized to one of the four 16-week treatment conditions: standard psychosocial treatment or psychosocial treatment plus one of the three durations of CM (one-month, two-month, or four-month). A total of 118 participants were randomized to the four treatment conditions. There were significant differences across treatment conditions for number of consecutive days of methamphetamine abstinence (p<0.05). These differences were in the hypothesized direction, as participants were more likely to remain abstinent through the 16-week trial as CM duration increased. A significant effect of treatment condition (p<0.05) and time (p<0.05) on abstinence over time was also found. Longer durations of CM were more effective for maintaining methamphetamine abstinence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.